Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,114,938 papers from all fields of science
Search
Sign In
Create Free Account
GW 501516
Known as:
GW-501516
, GW501516
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (2)
GW 1516
endurobol
Broader (1)
Thiazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
PPARδ Agonist GW501516 Inhibits PDGF-Stimulated Pulmonary Arterial Smooth Muscle Cell Function Related to Pathological Vascular Remodeling
Guangjie Liu
,
Xuan Li
,
+5 authors
Yongchang Sun
BioMed Research International
2013
Corpus ID: 17879157
Pulmonary arterial hypertension (PAH) is a severe and progressive disease, a key feature of which is pulmonary vascular…
Expand
Review
2013
Review
2013
Harnessing the benefits of PPARβ/δ agonists.
L. Mackenzie
,
L. Lione
Life Science
2013
Corpus ID: 5388960
2009
2009
Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503.
M. Thevis
,
S. Beuck
,
+4 authors
W. Schänzer
Rapid Communications in Mass Spectrometry
2009
Corpus ID: 27248650
An important aspect of preventive doping research is the rapid implementation of tests for emerging drugs with potential for…
Expand
2007
2007
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Holly E. Hollingshead
,
Renee L. Killins
,
+7 authors
J. Peters
Carcinogenesis
2007
Corpus ID: 23918627
Ligands for peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) increase skeletal muscle fatty acid catabolism…
Expand
2007
2007
The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
N. Dimopoulos
,
M. Watson
,
C. Green
,
H. Hundal
FEBS Letters
2007
Corpus ID: 40347100
Peroxisome proliferator-activated receptor-delta (PPARdelta) activation enhances skeletal muscle fatty acid oxidation and…
Expand
2007
2007
Lipids, Lipoproteins, and Peroxisome Proliferator Activated Receptor-δ
D. Sprecher
2007
Corpus ID: 73115470
2006
2006
Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.
M. Pesant
,
S. Sueur
,
+4 authors
J. Connat
Cardiovascular Research
2006
Corpus ID: 1260580
OBJECTIVE Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma plays beneficial roles in…
Expand
2005
2005
Nanomolar and Micromolar Effects of 15-Deoxy-Δ12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors γ and δ and Nuclear…
E. B. Berry
,
J. Keelan
,
R. Helliwell
,
R. Gilmour
,
M. Mitchell
Molecular Pharmacology
2005
Corpus ID: 26776613
15-Deoxy Δ12,14-prostaglandin J2 (15d-PGJ2), an activator of peroxisome proliferator-activated receptor (PPAR)-γ and -δ, is a…
Expand
2005
2005
Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and…
Shouwei Han
,
J. Ritzenthaler
,
B. Wingerd
,
J. Roman
Journal of Biological Chemistry
2005
Corpus ID: 24813640
The prostaglandin E2 receptor subtype EP4 has been implicated in the growth and progression of human non-small cell lung…
Expand
2004
2004
Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation.
Zhi-Liang Wei
,
P. Petukhov
,
+6 authors
A. Kozikowski
Journal of the American Chemical Society
2004
Corpus ID: 40555750
The peroxisome proliferator-activated receptors (PPARs) are important molecular targets for the development of drugs for the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE